Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

Abstract Background Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs and regimens including bedaquiline and linezolid. The level of pyrazinamide resistance among MDR-TB patie...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hui Xia, Susan van den Hof, Frank Cobelens, Yang Zhou, Bing Zhao, Shengfen Wang, Yanlin Zhao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-01-01
Colecção:	BMC Infectious Diseases
Assuntos:	Multidrug-resistant tuberculosis Pyrazinamide Resistance pncA
Acesso em linha:	https://doi.org/10.1186/s12879-020-4758-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!